Pricing

Astria Therapeutics Inc (ATXS)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jill C. Milne
Employees:
30
75 STATE STREET, SUITE 1400, BOSTON, MA, 02109
617-349-1971
Stock Split History
DateRatio
2018-12-28 1:10
2018-12-31 1:10
2021-08-20 1:6
Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available